BACKGROUND AND OBJECTIVE: Ovarian cancer has an extremely high mortality rate resulting from poor understanding of the disease. In order to aid understanding of disease etiology and progression, we identify the endogenous fluorophores present in a mouse model of ovarian cancer and describe changes in fluorophore abundance and distribution with age and disease. STUDY DESIGN/ MATERIALS AND METHODS: A mouse model of ovarian cancer was created by dosing with 4-vinylcyclohexene diepoxide, which induces follicular apoptosis (simulating menopause), and 7,12-dimethylbenz[a]anthracene, a known carcinogen. Imaging of ovarian tissue was completed ex vivo with a multiphoton microscope using excitation wavelength of 780 nm and emission collection from 405 to 505 nm. Two-photon excited fluorescence images and corresponding histologic sections with selective stains were used to identify endogenous fluorophores. RESULTS: The majority of collected fluorescence emission was attributed to NADH and lipofuscin, with additional contributions from collagen and elastin. Dim cellular fluorescence from NADH did not show observable changes with age. Changes in ovarian morphology with disease development frequently caused increased fluorescence contributions from collagen and adipose tissue-associated NADH. Lipofuscin fluorescence was much brighter than NADH fluorescence and increased as a function of both age and disease. CONCLUSIONS: Our finding of NADH fluorescence patterns similar to that seen previously in human ovary, combined with the observation of lipofuscin accumulation with age and disease also seen in human organs, suggests that the findings from this model may be relevant to human ovarian disease. Increased lipofuscin fluorescence might be used as an indicator of disease in the ovary and this finding warrants further study.
BACKGROUND AND OBJECTIVE:Ovarian cancer has an extremely high mortality rate resulting from poor understanding of the disease. In order to aid understanding of disease etiology and progression, we identify the endogenous fluorophores present in a mouse model of ovarian cancer and describe changes in fluorophore abundance and distribution with age and disease. STUDY DESIGN/ MATERIALS AND METHODS: A mouse model of ovarian cancer was created by dosing with 4-vinylcyclohexene diepoxide, which induces follicular apoptosis (simulating menopause), and 7,12-dimethylbenz[a]anthracene, a known carcinogen. Imaging of ovarian tissue was completed ex vivo with a multiphoton microscope using excitation wavelength of 780 nm and emission collection from 405 to 505 nm. Two-photon excited fluorescence images and corresponding histologic sections with selective stains were used to identify endogenous fluorophores. RESULTS: The majority of collected fluorescence emission was attributed to NADH and lipofuscin, with additional contributions from collagen and elastin. Dim cellular fluorescence from NADH did not show observable changes with age. Changes in ovarian morphology with disease development frequently caused increased fluorescence contributions from collagen and adipose tissue-associated NADH. Lipofuscin fluorescence was much brighter than NADH fluorescence and increased as a function of both age and disease. CONCLUSIONS: Our finding of NADH fluorescence patterns similar to that seen previously in humanovary, combined with the observation of lipofuscin accumulation with age and disease also seen in human organs, suggests that the findings from this model may be relevant to humanovarian disease. Increased lipofuscin fluorescence might be used as an indicator of disease in the ovary and this finding warrants further study.
Authors: Warren R Zipfel; Rebecca M Williams; Richard Christie; Alexander Yu Nikitin; Bradley T Hyman; Watt W Webb Journal: Proc Natl Acad Sci U S A Date: 2003-05-19 Impact factor: 11.205
Authors: Javier Adur; Vitor B Pelegati; Leverson F L Costa; Luciana Pietro; Andre A de Thomaz; Diogo B Almeida; Fatima Bottcher-Luiz; Liliana A L A Andrade; Carlos L Cesar Journal: J Biomed Opt Date: 2011-09 Impact factor: 3.170
Authors: Elizabeth M Kanter; Ross M Walker; Samuel L Marion; Molly Brewer; Patricia B Hoyer; Jennifer K Barton Journal: J Biomed Opt Date: 2006 Jul-Aug Impact factor: 3.170
Authors: Alan D Marmorstein; Lihua Y Marmorstein; Hirokazu Sakaguchi; Joe G Hollyfield Journal: Invest Ophthalmol Vis Sci Date: 2002-07 Impact factor: 4.799
Authors: Anthony A Tanbakuchi; Joshua A Udovich; Andrew R Rouse; Kenneth D Hatch; Arthur F Gmitro Journal: Am J Obstet Gynecol Date: 2009-10-03 Impact factor: 8.661
Authors: Giju Thomas; Johan van Voskuilen; Hoa Truong; Ji-Ying Song; Hans C Gerritsen; H J C M Sterenborg Journal: Biomed Opt Express Date: 2014-11-13 Impact factor: 3.732
Authors: Gabriel V Orsinger; Jennifer M Watson; Michael Gordon; Ariel C Nymeyer; Erich E de Leon; Johnathan W Brownlee; Kenneth D Hatch; Setsuko K Chambers; Jennifer K Barton; Raymond K Kostuk; Marek Romanowski Journal: J Biomed Opt Date: 2014-03 Impact factor: 3.170
Authors: Travis W Sawyer; Jennifer W Koevary; Caitlin C Howard; Olivia J Austin; Photini F S Rice; Gabrielle V Hutchens; Setsuko K Chambers; Denise C Connolly; Jennifer K Barton Journal: Lasers Surg Med Date: 2020-04-20 Impact factor: 4.025
Authors: Kelli C Kiekens; David Vega; Harrison T Thurgood; Dominique Galvez; Davis J McGregor; Travis W Sawyer; Jennifer K Barton Journal: J Eng Sci Med Diagn Ther Date: 2021-04-22
Authors: Jennifer M Watson; Samuel L Marion; Photini F Rice; David L Bentley; David G Besselsen; Urs Utzinger; Patricia B Hoyer; Jennifer K Barton Journal: Cancer Biol Ther Date: 2013-10-03 Impact factor: 4.742
Authors: Travis W Sawyer; Jennifer W Koevary; Faith P S Rice; Caitlin C Howard; Olivia J Austin; Denise C Connolly; Kathy Q Cai; Jennifer K Barton Journal: J Biomed Opt Date: 2019-09 Impact factor: 3.170